1.State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan 430079, China
2.Department of Oral Maxillofacial-Head Neck Oncology, School and and Hospital of Stomatology, Wuhan University, Wuhan 430079, China
Author bio:
*luzhang2012@whu.edu.cn;
sunzj@whu.edu.cn
Funds:
the National Natural Science Foundation of China(82273202;82370948;82072996;82170941);the Fundamental Research Funds for the Central Universities(2042022dx0003);the Hubei Province International Science and Technology Cooperation Project(2021EHB027);the National Key Research and Development Program(2022YFC2504200)
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy[J]. MMR, 2024,11(6):863-886.
Cite this article as: Xiong D, Zhang L, Sun ZJ. Targeting the epigenome to reinvigorate T cells for cancer immunotherapy. Mil Med Res. 2023;10(1):59.
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy[J]. MMR, 2024,11(6):863-886. DOI: 10.1186/s40779-023-00496-2.
Cite this article as: Xiong D, Zhang L, Sun ZJ. Targeting the epigenome to reinvigorate T cells for cancer immunotherapy. Mil Med Res. 2023;10(1):59. DOI: 10.1186/s40779-023-00496-2.
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy